|
|
Article: New generation of Claritin gets approval from FDA
- Article from:
- The Milwaukee Journal Sentinel (Milwaukee, WI)
- Article date:
- December 25, 2001
CopyrightCopyright 2001 The Milwaukee Journal Sentinel. Provided by ProQuest LLC. (Hide copyright information)
|
New generation of Claritin gets approval from FDA
But generics could pose threat to Schering-Plough revenue in '03
Associated Press
Tuesday, December 25, 2001
New York -- The Food and Drug Administration gave Schering-Plough
Corp. an early Christmas present last week when it finally approved
its second-generation allergy medication Clarinex after a year. But
whether it is a gift that keeps on giving remains a matter of debate.
Clarinex is the successor drug to Claritin, Schering's top-
selling drug. Claritin sales reached $3 billion last year, nearly one-
third of Schering's revenue of $9.2 billion.
However, 18 generic drug companies are challenging Claritin's
patents in a court case that is ...